Skip to main content
Caplight Logo









Alt Biotech

Alt Biotech

Private
FranceHealthcare & Life Scienceshttps://www.alt-biotech.com/

Last Round

Grant

Sep 18, 2024

Total Funding Raised

$661,000

Company Overview

Alt Biotech is a biotechnology company that develops an innovative bioproduction method to generate affordable, high-quality growth factors, cytokines, and hormones for cell culture.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

animal-free growth factorsrecombinant proteinscellular agriculturelab-grown meatbioproductioncell culture mediacytokinescell therapycultivated meatmicrobial engineeringregenerative medicinebiotech reagentsfetal bovine serum replacementFBS alternativeorganoid development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Alt Biotech Comparables

Compare Alt Biotech with similar companies based on industry and business-model similarity.

Alt Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Bright Biotech
87%
Multus Biotechnology
84%
Core Biogenesis
81%

Alt Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 18, 2024
AcceleratorJan 25, 2024
DebtNov 2, 2023
AcceleratorMay 23, 2023

Alt Biotech Investors

Notable investors and investment history

Alt Biotech investors
InvestorRounds
Biotope by VIBAccelerator
Ministry of Higher Education and ResearchGrant
GenopoleDebt
BpifranceGrant
CDG InvestAccelerator
212 FoundersAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 18, 2024

    $640K grant received from Bpifrance and Ministry of Higher Education and Research.

Alt Biotech Filings

Explore SEC and related filing metadata, where available.

Alt Biotech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Alt Biotech's valuation, stock price, and market status.

Is Alt Biotech a public or private company?

Alt Biotech is a private company.

What is the current stock price of Alt Biotech?

Alt Biotech is a private company with no public stock price. No recent secondary market data is available.

How much is Alt Biotech worth (valuation)?

Valuation information for Alt Biotech is not publicly available.

Can I buy Alt Biotech stock?

Alt Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Alt Biotech's last funding round?

Alt Biotech's most recent funding round was Grant on September 18, 2024.

Who are the main investors in Alt Biotech?

Key investors in Alt Biotech include CDG Invest.

Will Alt Biotech IPO soon?

No public IPO plans have been announced for Alt Biotech.

How can I track Alt Biotech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Alt Biotech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersFrance
Year Founded2023
Last FundingSep 18, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?